Researchers found that combining trametinib, rigosertib, and a CD40 agonist blocked immune-suppressive B cells and restored ...
PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the ...
Exl-111 is an investigational allergic Effector Cell Response Inhibitor (ECRI) targeting the IgE axis and is designed to disarm allergic ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsAlbert Bourla - Chairman of the Board ...
A clinical trial is evaluating an experimental therapy that blocks inflammatory signals associated with Parkinson’s disease ...
UConn School of Medicine offering innovative clinical trial testing novel pill's impact for reducing inflammation to treat ...
Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...
The worst story moves in soaps from February, from GH's non-triangle for Maxie and Mariah kidnapping Dominic on Y&R.
Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, today's ...
Mean absolute fetal hemoglobin (HbF) increased by 12.2% (from 7.1% to 19.3%) at Week 12 (n=12), representing a rapid, robust, and clinically ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results